Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com
View Top Employees from NicoxWebsite | http://www.nicox.com |
Ticker | COX |
Revenue | $10 million |
Funding | $31.8 million |
Employees | 55 (49 on RocketReach) |
Founded | 1996 |
Address | Drakkar 2 Batiment D, Valbonne, Provence-Alpes-Cote d'Azur 06560, FR |
Phone | +33 4 97 24 53 00 |
Fax | +33 4 97 24 53 99 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Science and Engineering, Ophthalmology, Healthcare, Health Care, Research and Development, Medical Device |
Web Rank | 6 Million |
Keywords | Nicox, Nicox Career, Nicox Label, Nicox Aciex |
Competitors | ARYx Therapeutics Inc., Calistoga Pharmaceuticals, Diatos, OxThera, TaiGen Biotechnology |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Nicox employee's phone or email?
The Nicox annual revenue was $10 million in 2024.
Andreas Segerros is the CEO of Nicox.
49 people are employed at Nicox.
Nicox is based in Valbonne, Provence-Alpes-Cote d'Azur.
The NAICS codes for Nicox are [3254, 32541, 32, 325].
The SIC codes for Nicox are [28, 283].